the Institute for biological research Israel announced the completion of a program for the development of effective treatment of a new type of coronavirus. We are talking about the so-called “passive vaccine”, the antibodies that can attack the virus COVID-19 in the human body and neutralize it. It is noted that the technology now is at the stage of patenting, for the possibility of further commercial use.
Israeli defence Minister Naftali Bennett visited the laboratory of the Institute on Monday, where he was presented with the results. According to The Jerusalem Post, the defense Minister had praised the work of specialists. “I’m proud of the staff of the Biological Institute, the perpetrators of this great breakthrough,” the Minister said at a press conference, adding that to this amazing achievement brought “Jewish creativity and ingenuity”.
No precise time of appearance of the drug on the market called, exactly as the names of pharmaceutical companies that could potentially produce. Recall that Israel was one of the first countries that closed their borders and impose strict restrictions on the movement of the background of the outbreak of coronavirus. At the moment we know of 16 identified 246 cases and 235 deaths from this disease.
